{"text": ["Mirikizumab", "Demonstrates", "Superiority", "over", "Placebo", "in", "Phase", "3", "Maintenance", "Study", "in", "Ulcerative", "Colitis,", "Supporting", "Regulatory", "Submissions", "in", "2022"], "created_at": "2021-12-14 22:00:00"}
{"text": ["Eli", "Lilly", "Strikes", "Deal", "With", "Chinese", "Company", "on", "New", "Drugs", "for", "Diabetes"], "created_at": "2021-12-14 21:28:49"}
{"text": ["Who", "Has", "What?", "Omicron", "Raises", "Stakes", "for", "Quick", "Covid", "Sequencing"], "created_at": "2021-12-14 17:18:21"}
{"text": ["PFE", "vs.", "LLY:", "Which", "Stock", "Should", "Value", "Investors", "Buy", "Now?"], "created_at": "2021-12-14 16:40:04"}
{"text": ["Foghorn", "(FHTX)", "Surges", "on", "Oncology", "Collaboration", "With", "Lilly"], "created_at": "2021-12-14 15:10:03"}
{"text": ["Company", "News", "for", "Dec", "14,", "2021"], "created_at": "2021-12-14 14:35:02"}
{"text": ["Eli", "Lilly", "and", "Foghorn", "Partner", "Up.", "Foghorn", "Stock", "Soared."], "created_at": "2021-12-14 00:55:00"}
